
1. Emerging Infections
2. Global Health
3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics
5. Bioterrorism Preparedness
6. Surveillance for communicable diseases
7. Antimicrobial resistance
Education and Training
- Fellow in Infectious Diseases, Medicine, Duke University, 2001 - 2002
- Fellow in Infectious Diseases, Medicine, Duke University, 1999 - 2000
- Medical Resident, Medicine, Duke University, 1994 - 1997
- M.D., Duke University, 1994
Grants
- Antibacterial Resistance Leadership Group (ARLG)
- CIVICs Component C -Option 13 Equitable Adj #2
- Early life B cell responses and inflammation following SARS-CoV-2 infection
- Platelet-mast cell interactions in pathogen induced vascular pathology
- Sepsis Characterization in Kilimanjaro (R01)
- Interdisciplinary Research Training Program in AIDS
- CIVICS Component C - Option 13A
- RADx-UP CDCC
- Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19
- Host response-based diagnostics for identifying bacterial versus viral causes of lower respiratory infection in resource-limited settings
- Vaccine and Treatment Evaluation Units (VTEU)
- Rapid, point-of-care, host gene expression test for presymptomatic viral infection and to distinguish bacterial from viral illness
- Inflammatory and Metabolic Biomarkers in Cardiovascular Complications with SARS-CoV-2
- Duke CTSA (TL1) Year 5
- COVID Survivors Long Term Follow Up Study--WMD ECHO Detector
- HERO Program, HERO Registry, HERO-HCQ Trial
- EPCTU - Task Area A - Admin and Overall
- ID NOW Clinical Evaluation
- Duke RDS2 (Respondent-Driven Sampling, Respiratory Disease Surveillance) the SNOWBALL Sampling Study
- Clinical Vaccine Safety Evaluation - Contributing Site - Task COVID - Optional Task 3
- CIVICS Component C - Option 2
- VTEU 18-0010.B1C1.0120_Task C Option 1
- Duke Resident Physician-Scientist Program - NIAID
- VTEU TO #132 Base - HHSN272201300017I TO 75N93019F00132 Task Area A - FY.2020.A1B1C1D1.0123 - Option 2.A
- Yellow Fever Vaccine Trial - U44 Clinical Trial with Najit